Risk factors for breakthrough COVID-19 infections in solid organ transplant recipients receiving tixagevimab/cilgavimab for pre-exposure prophylaxis

Transplant Infectious DiseaseEarly View e14125 LETTER TO THE EDITOR Risk factors for breakthrough COVID-19 infections in solid organ transplant recipients receiving tixagevimab/cilgavimab for pre-exposure prophylaxis Dana L. Abraham, Dana L. Abraham orcid.org/0000-0001-8658-3750 Department of Pharmacy, University of California San Diego Health, La Jolla, California, USASearch for more papers by this authorAlicia B. Lichvar, Alicia B. Lichvar orcid.org/0000-0003-3804-6517 Department of Pharmacy, University of California San Diego Health, La Jolla, California, USA Center for Transplantation, University of California San Diego Health, La Jolla, California, USASearch for more papers by this authorAleah L. Brubaker, Aleah L. Brubaker orcid.org/0000-0003-4795-2562 Center for Transplantation, University of California San Diego Health, La Jolla, California, USASearch for more papers by this authorNina Haste, Nina Haste Department of Pharmacy, University of California San Diego Health, La Jolla, California, USASearch for more papers by this authorVictor Chen, Victor Chen Department of Pharmacy, University of California San Diego Health, La Jolla, California, USASearch for more papers by this authorShira Abeles, Shira Abeles Division of Transplant and Hepatobiliary Surgery, Department of Surgery, University of California San Diego Health, La Jolla, California, USASearch for more papers by this authorSaima Aslam, Saima Aslam orcid.org/0000-0002-4051-5629 Division of Transplant and Hepatobiliary Surgery, Department of Surgery, University of California San Diego Health, La Jolla, California, USASearch for more papers by this authorNancy Yam, Nancy Yam Department of Pharmacy, University of California San Diego Health, La Jolla, California, USASearch for more papers by this authorLucy Horton, Lucy Horton Division of Transplant and Hepatobiliary Surgery, Department of Surgery, University of California San Diego Health, La Jolla, California, USASearch for more papers by this authorBenjamin Chen, Benjamin Chen orcid.org/0000-0003-4232-2457 Division of Transplant and Hepatobiliary Surgery, Department of Surgery, University of California San Diego Health, La Jolla, California, USASearch for more papers by this authorNancy Binkin, Nancy Binkin Herbert Wertheim School of Public Health and Human Longevity, University of California San Diego, La Jolla, California, USASearch for more papers by this authorNancy Law, Corresponding Author Nancy Law [email protected] orcid.org/0000-0002-2846-2691 Division of Transplant and Hepatobiliary Surgery, Department of Surgery, University of California San Diego Health, La Jolla, California, USA Division of Infectious Diseases and Global Health, University of California San Diego Health, La Jolla, California, USA Correspondence Nancy Law, Division of Infectious Diseases and Global Health, University of California San Diego Health, 9300 Campus Point Drive, La Jolla, CA 92037, USA. Email: [email protected]Search for more papers by this author Dana L. Abraham, Dana L. Abraham orcid.org/0000-0001-8658-3750 Department of Pharmacy, University of California San Diego Health, La Jolla, California, USASearch for more papers by this authorAlicia B. Lichvar, Alicia B. Lichvar orcid.org/0000-0003-3804-6517 Department of Pharmacy, University of California San Diego Health, La Jolla, California, USA Center for Transplantation, University of California San Diego Health, La Jolla, California, USASearch for more papers by this authorAleah L. Brubaker, Aleah L. Brubaker orcid.org/0000-0003-4795-2562 Center for Transplantation, University of California San Diego Health, La Jolla, California, USASearch for more papers by this authorNina Haste, Nina Haste Department of Pharmacy, University of California San Diego Health, La Jolla, California, USASearch for more papers by this authorVictor Chen, Victor Chen Department of Pharmacy, University of California San Diego Health, La Jolla, California, USASearch for more papers by this authorShira Abeles, Shira Abeles Division of Transplant and Hepatobiliary Surgery, Department of Surgery, University of California San Diego Health, La Jolla, California, USASearch for more papers by this authorSaima Aslam, Saima Aslam orcid.org/0000-0002-4051-5629 Division of Transplant and Hepatobiliary Surgery, Department of Surgery, University of California San Diego Health, La Jolla, California, USASearch for more papers by this authorNancy Yam, Nancy Yam Department of Pharmacy, University of California San Diego Health, La Jolla, California, USASearch for more papers by this authorLucy Horton, Lucy Horton Division of Transplant and Hepatobiliary Surgery, Department of Surgery, University of California San Diego Health, La Jolla, California, USASearch for more papers by this authorBenjamin Chen, Benjamin Chen orcid.org/0000-0003-4232-2457 Division of Transplant and Hepatobiliary Surgery, Department of Surgery, University of California San Diego Health, La Jolla, California, USASearch for more papers by this authorNancy Binkin, Nancy Binkin Herbert Wertheim School of Public Health and Human Longevity, University of California San Diego, La Jolla, California, USASearch for more papers by this authorNancy Law, Corresponding Author Nancy Law [email protected] orcid.org/0000-0002-2846-2691 Division of Transplant and Hepatobiliary Surgery, Department of Surgery, University of California San Diego Health, La Jolla, California, USA Division of Infectious Diseases and Global Health, University of California San Diego Health, La Jolla, California, USA Correspondence Nancy Law, Division of Infectious Diseases and Global Health, University of California San Diego Health, 9300 Campus Point Drive, La Jolla, CA 92037, USA. Email: [email protected]Search for more papers by this author First published: 18 August 2023 https://doi.org/10.1111/tid.14125Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1Fact Sheet for Healthcare Providers: Emergency Use Authorization For EvusheldTM (Tixagevimab Co-Packaged With Cilgavimab). Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2021. 2Levin MJ, Ustianowski A, De Wit S, et al. Intramuscular AZD7442 (tixagevimab–cilgavimab) for prevention of Covid-19. N Engl J Med. 2022; 386: 2188-2200. 3Qin CX, Moore LW, Anjan S, et al. Risk of breakthrough SARS-CoV-2 infections in adult transplant recipients. Transplantation. 2021; 105(11): e265-e266. Early ViewOnline Version of Record before inclusion in an issuee14125 ReferencesRelatedInformation